S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 Stocks That Flourish In The Fall
2 Must-Have Silicon Companies That Don't Make Microchips
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
Small Caps That Have Priced In A Hard Landing For Big Upside
OTCMKTS:CLPBF

Coloplast A/S (CLPBF) Stock Forecast, Price & News

$110.99
0.00 (0.00%)
(As of 09/25/2023 ET)
Compare
Today's Range
$110.99
$110.99
50-Day Range
$110.13
$127.75
52-Week Range
$95.75
$145.05
Volume
12 shs
Average Volume
154 shs
Market Capitalization
N/A
P/E Ratio
9.72
Dividend Yield
6.76%
Price Target
N/A

CLPBF stock logo

About Coloplast A/S (OTCMKTS:CLPBF) Stock

Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, it offers voice and respiratory products, including medical devices for neck stoma under the Provox brand; and products for tracheostoma under the TRACOE brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

CLPBF Price History

CLPBF Stock News Headlines

Coloplast A/S - Financial Calendar 2023-24
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
Coloplast completes the acquisition of Kerecis
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
Coloplast Introduces Next-Generation Catheter
Coloplast A/S Series B
Coloplast A/S (COLO-B.CO)
See More Headlines
Receive CLPBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Coloplast A/S and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CLPBF
Fax
N/A
Employees
14,700
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Kristian Villumsen (Age 53)
    Pres & CEO
    Comp: $2.24M
  • Mr. Anders Lonning-Skovgaard (Age 51)
    Exec. VP & CFO
    Comp: $1.14M
  • Mr. Allan Rasmussen (Age 56)
    Exec. VP of Global Operations
    Comp: $1.01M
  • Mr. Nicolai Buhl Andersen (Age 54)
    Exec. VP of Innovation
    Comp: $969.63k
  • Mr. Paul Marcun (Age 56)
    Exec. VP of Growth
    Comp: $1.16M
  • Mr. Thomas Barfod (Age 53)
    Sr. Controller & Employees Representative Director
    Comp: $64.17k
  • Ellen Bjurgert
    VP of Investor Relations
  • Dennis Kaysen
    Director of Corp. Communications
  • Dorthe Ronnau (Age 57)
    Sr. VP of People & Culture
  • Mr. Alain Morvan
    Sr. VP of Sales Europe













CLPBF Stock - Frequently Asked Questions

How have CLPBF shares performed in 2023?

Coloplast A/S's stock was trading at $115.0050 at the beginning of the year. Since then, CLPBF stock has decreased by 3.5% and is now trading at $110.99.
View the best growth stocks for 2023 here
.

Are investors shorting Coloplast A/S?

Coloplast A/S saw a increase in short interest in the month of August. As of August 15th, there was short interest totaling 618,400 shares, an increase of 6.0% from the July 31st total of 583,400 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 6,184.0 days.
View Coloplast A/S's Short Interest
.

Is Coloplast A/S a good dividend stock?

Coloplast A/S (OTCMKTS:CLPBF) pays an annual dividend of $7.50 per share and currently has a dividend yield of 1.54%. The dividend payout ratio is 65.69%. This payout ratio is at a healthy, sustainable level, below 75%.

What is Coloplast A/S's stock symbol?

Coloplast A/S trades on the OTCMKTS under the ticker symbol "CLPBF."

How do I buy shares of Coloplast A/S?

Shares of CLPBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Coloplast A/S's stock price today?

One share of CLPBF stock can currently be purchased for approximately $110.99.

How many employees does Coloplast A/S have?

The company employs 14,700 workers across the globe.

How can I contact Coloplast A/S?

Coloplast A/S's mailing address is Holtedam 1-3, Humlebaek, Zealand 3050. The official website for the company is www.coloplast.com. The company can be reached via phone at (454) 911-1111.

This page (OTCMKTS:CLPBF) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -